Skip to main content
. 2019 Jan 10;14:105–111. doi: 10.2147/CIA.S189040

Table 1.

Comparison of patients’ characteristics based on frailty status

Characteristics Nonfrailty (n=140) Prefrailty (n=81) Frailty (n=159) P-value
Demographic
Age (years) 77.69±7.67 85.43±6.21* 86.75±5.80Δ <0.001a
Male (%) 51 (57.9) 43 (53.1) 93 (58.5) 0.710b
BMI (kg/m2) 23.60±3.13 23.33±4.56 23.39±4.11 0.857a
Educational level (high/middle/low) (%) 30.7/47.1/22.1 29.6/49.4/21.0 34.6/47.2/18.2 0.582b
Medical
Cardiovascular disease (%) 78 (55.7) 45 (55.5) 90 (56.6) 0.173b
Cerebrovascular disease (%) 33 (23.6) 18 (22.2) 30 (18.8) 0.102b
Diabetes (%) 15 (10.7) 10 (12.3) 19 (11.9) 0.093b
Fall history (%) 19 (13.6) 17 (21.0) 44 (27.7)Δ 0.011b
Grip strength (kg) 30.76±8.86 22.81±7.30* 21.36±7.58Δ,# <0.001a
Polypharmacy (%) 50 (35.7) 54 (66.7)* 118 (74.2)Δ <0.001b
MNA-SF 13 (12–14) 12 (11–14)* 11 (10–13)Δ,# <0.001c
ADL 100 (100–100) 100 (95–100) 90 (75–100)Δ,# <0.001c
IADL 8 (8–8) 7 (5–8)* 3 (2–5)Δ,# <0.001c
MMSE 27 (25–29) 25 (22–27)* 23 (18–27)Δ <0.001c
POMA 26 (25–28) 21 (17–24)* 18 (15–23)Δ,# <0.001c
Serum biomarkers
TFN (g/L) 2.37±0.30 2.08±0.28* 2.06±0.26Δ <0.001a
PA (mg/L) 237.89±47.56 201.91±40.16* 212.07±48.26Δ <0.001a
TP (mg/L) 69.88±4.43 66.02±5.23* 62.76±4.60Δ <0.001a
ALB (g/L) 41.71±3.27 38.10±4.44* 38.07±3.87 <0.001a
RBP (mg/L) 42.96±10.12 39.59±11.77 40.38±12.25 0.063a
Hb (g/L) 125.45±8.73 119.54±12.25* 117.33±11.83Δ <0.001a

Notes: Three groups were considered:

a

one-way ANOVA;

b

Pearson’s chi-squared test;

c

Kruskal–Walls test. Two groups were considered: LSD t-test (for normally distributed continuous data), chi-squared test (for categorical data), Mann–Whitney U-test (for nonnormally distributed continuous data).

*

P<0.05, prefrail vs nonfrail;

Δ

P<0.05, frail vs nonfrail;

#

P<0.05, frail vs prefrail.

Abbreviations: ADL, activities of daily living; ALB, albumin; BMI, body mass index; Hb, hemoglobin; IADL, instrumental ADL; MMSE, Mini-Mental State Examination; MNA-SF, mini nutritional assessment-short form; PA, prealbumin; POMA, performance-oriented mobility assessment; RBP, retinol-binding protein; TNF, transferrin; TP, total protein.